
How can we envision the best for people, their health, balance, and well-being?
21st by CentraleSupélec accelerates the development of innovative startups in the fields of health, medical research, medtech/biotech, healthy aging, and education.
‍
The accelerator is partnering with the group Ramsay SantĂ©, one of Europe's leaders in private hospitalization and primary care (36,000 employees and 8,600 practitioners).Â
‍
#HealthTech #MedTech startups supported by 21st will thus have the opportunity to test their solution, subject to acceptance by the relevant institutions, within the group's living labs.Â
‍
Why join us?
‍
âś” Strategy | Excellent strategic support with business coaching, impact, and masterclasses.
‍
✔ Mentoring | Advice from a CentraleSupélec alumnus, a successful mentor and entrepreneur.
‍
✔ Funding | Funding opportunities through honor loans of up to €90K and equity investments of up to €500K, in partnership with CentraleSupélec Venture.
‍
âś” Research | A world-class research and innovation ecosystem, with 18 laboratories, 26 chairs, and 400 research faculty at the heart of Paris-Saclay.
‍
✔ Community | A network of over 45,000 CentraleSupélec alumni working worldwide and across all sectors.
‍
Increasing the efficiency of autoimmune disease research with AI: Meet Scienta Lab, a startup accelerated by 21st.Â
‍
🧬 Like Scienta Lab, join the 21st by CentraleSupélec accelerator
‍





.png)
